CD57+ EMRA CD8+ T cell proportion

1 paper1 finding

Humans1

Associations

1

Chemotherapy

upin humans1

1 study

Chemotherapy is associated with CD57+ EMRA CD8+ T cell proportion in humans.
“Chemotherapy prior to anti-PD-1/PD-L1 was associated with an increased proportion of CD57+ EMRA CD8+ T cells (p = 0.009)”
Humanscancer; assessed before anti-PD-1/PD-L1 therapyn = 35
CD57⁺ EMRA CD8⁺ T cells in cancer patients over 70: associations with prior chemotherapy and response to anti-PD-1/PD-L1 therapy
Immunity & ageing : I & A27 Dec 2024

More on Chemotherapy

Latest

Immunity & Ageing28 Dec

CD57⁺ EMRA CD8⁺ T cells in cancer patients over 70: associations with prior chemotherapy and response to anti-PD-1/PD-L1 therapy

Cohort study of 35 peopleBlood and immune system